CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

Interferential Current Stimulation (IFS) — Coverage Criteria

Defines coverage stance for interferential current stimulation for BCBSRI members, distinguishing Medicare Advantage Plans (medically necessary) from Commercial Products (not medically necessary). Applies to providers billing BCBSRI.

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicyInterferential Current Stimulation (IFS) — Coverage Criteria

Policy CodePolicy N/A

Change TypeNo material changes

Effective DateMar 3, 2023

Next Review Date

Key ActionDocument objective or subjective improvement within 6 visits and justify use beyond 12 visits when billing for electrical stimulation.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

Medicare Advantage: medically necessaryMedicare Advantage

Commercial: not medically necessaryCommercial

2 codesDevice codes

No medical criteriaMedical criteria

Coverage Determinations

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Product-specific coverage determination

Coverage stance differs by product:

Medicare Advantage Plans: Interferential current stimulation is considered medically necessary for Medicare Advantage Plans; BCBSRI follows CMS guidelines which may affect coverage.

See note about following CMS NCDs/LCDs

Commercial Products: Interferential current stimulation is considered not medically necessary for Commercial Products because evidence is insufficient to determine effects on health outcomes.

Benefits may vary by contract; refer to member certificate or subscriber agreement.

Coding and Billing Guidance

Medicare Advantage Plans and Commercial ProductsHCPCS

S8130	Interferential current stimulator; 2 channel
S8131	Interferential current stimulator; 4 channel

Medicare Advantage PlansHCPCSCovered

S8130	Interferential current stimulator; 2 channel
S8131	Interferential current stimulator; 4 channel

Commercial ProductsHCPCSNot Covered

S8130	Interferential current stimulator; 2 channel
S8131	Interferential current stimulator; 4 channel

Billing guidance for electrical stimulation modalitiesHCPCS | CPT

G0283	Application of a modality to one or more areas; unattended electrical stimulation (e.g., interferential current, TENS)
97032	Application of a modality to one or more areas; electrical stimulation (manual), used for training in home TENS unit

Treatment response window — improvement expected within 6 visits; documentation required beyond 12 visits

Expected treatment responseObjective and/or subjective improvement in swelling and/or pain is expected within 6 visits

Action if no improvementIf no improvement is noted within 6 visits, implement alternative strategies or re-evaluate continued use

Documentation for extended useDocumentation must clearly support the need for electrical stimulation for more than 12 visits

Home training implicationSome patients can be trained to use a home TENS unit; only 1–2 visits are generally necessary for training (billable as 97032)

Provider Requirements and Billing Instructions

Note

Prior Authorization

Not applicable

Billing Rule

Home unit training and billing guidance

Medicare Advantage Plans: Most non-wound care electrical stimulation treatments provided in therapy are billed as G0283 because they are typically provided in a supervised (unattended) manner after initial skilled application. Code G0283 is classified as a supervised modality — it does not require constant one-on-one contact by the provider. Examples of unattended electrical stimulation include interferential current, TENS, and cyclical muscle stimulation (Russian stimulation). These modalities should be used with appropriate therapeutic procedures to facilitate continued improvement. Coverage for muscle stimulation is limited to patients with intact nerve supply to the muscle (e.g., intact brain, spinal cord, and peripheral nerves) and for non-neurological causes of disuse atrophy (for example, post-casting or splinting, or contracture due to soft tissue scarring).

Most non-wound care electrical stimulation billed as G0283
Examples: interferential current, TENS, cyclical muscle stimulation (Russian)
G0283 = supervised modality (unattended)

Documentation Required

Required documentation and benefit verification

Documentation must demonstrate objective and/or subjective improvement in the targeted condition (for example, pain, swelling, or muscle function). If unattended electrical stimulation is used for control of pain or swelling, objective and/or subjective improvement should be documented within 6 visits. If no improvement is noted within 6 visits, the provider should re-evaluate and change the treatment plan (use alternative strategies) or document why continued use of the modality is necessary. Documentation must clearly support the medical necessity for electrical stimulation beyond 12 visits.

Document objective and/or subjective improvement in pain, swelling, or function
Re-evaluate and modify treatment if no improvement within 6 visits
Support medical necessity in documentation to justify >12 visits

Documentation Required

Documentation and treatment response requirements

Re-evaluate treatment response if no improvement within 6 visits; training for a home TENS unit generally requires only 1–2 visits (may be billed as 97032). After home unit training is completed and the patient continues with home use, G0283 should not be billed as an in-clinic treatment modality for that patient.

Home TENS training: typically 1–2 visits (billing code 97032)
Do not bill G0283 as an in-clinic treatment after home unit training is completed

Background

Interferential current stimulation (IFS) is an electrical stimulation technique that delivers two independent high- and medium-frequency alternating current circuits through superficial electrodes placed around the affected area. It has been investigated for reducing pain, improving function and range of motion, and treating other conditions, but there are no standardized protocols for frequency, duration, treatment time, or electrode placement. Because coverage and benefit determinations vary by product, review the member’s Certificate/Subscriber Agreement or Evidence of Coverage to confirm applicability of this policy.

Definitions

Interferential current stimulation (IFS) — technical definition

DefinitionInterferential current stimulation (IFS) uses two independent circuits carrying high‑ and medium‑frequency alternating currents delivered via superficial electrodes aligned around the affected area

Proposed advantageBelieved to penetrate tissues more effectively and cause less unwanted cutaneous nerve stimulation than TENS, often described as more comfortable

Variability in practiceNo standardized protocols for frequency, duration, treatment time, or electrode placement; device parameters and techniques may vary

Device clearanceSeveral IFS devices have received 510(k) clearance (e.g., Medstar 100, RS‑4i) and IFS may be included in multimodal electrotherapy devices